July 31, 2014
1 min read

Merck announces Q2 financial results

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Merck’s second-quarter worldwide sales were $10.9 billion, marking a 1% decrease from the same time last year, according to a company press release.

Pharmaceutical sales declined by 2% to $9.1 billion, while second-quarter global sales of consumer care products were $583 million, marking a 19% increase from the previous period in 2013. The increase includes a 1% negative impact due to foreign exchange, according to the press release.

Other revenues, accounting for alliance revenue, miscellaneous corporate revenues and third-party manufacturing sales, increased 9% to $392 million compared with the second quarter of 2013.

Merck reported that it expects full-year 2014 GAAP earnings per share to be between $4.44 and $4.77, and full-year 2014 revenues to be between $42.4 billion and $43.2 billion, according to the release.